Cargando…
Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastas...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156918/ https://www.ncbi.nlm.nih.gov/pubmed/15904519 http://dx.doi.org/10.1186/1475-2867-5-14 |
_version_ | 1782124334429503488 |
---|---|
author | Ervin, Heather Cox, James L |
author_facet | Ervin, Heather Cox, James L |
author_sort | Ervin, Heather |
collection | PubMed |
description | BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastasis we have over-expressed in B16 melanoma cells the natural cysteine protease inhibitor, cystatin C. We measured in vitro invasion of cystatin over-expression clones with Boyden chamber type assays. Tail-vein injections of cells were used to compare lung tumor colonization. Subcutaneous tumor growth and tumor cell metastasis from primary tumors were also analyzed. Apoptosis of tumor cells was measured in lung tissues following melanoma cell injection. RESULTS: Results show the in vitro invasion of cystatin C over-expressing cells was dramatically inhibited. Lung tumor colonization was also reduced. Increased tumor cell apoptosis was found to be an important factor and may be related to the reduced tumor burden noted in this system of melanoma metastasis. CONCLUSION: Cysteine proteases therefore, may be a target for future anti-metastatic therapies. |
format | Text |
id | pubmed-1156918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-11569182005-06-22 Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression Ervin, Heather Cox, James L Cancer Cell Int Primary Research BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastasis we have over-expressed in B16 melanoma cells the natural cysteine protease inhibitor, cystatin C. We measured in vitro invasion of cystatin over-expression clones with Boyden chamber type assays. Tail-vein injections of cells were used to compare lung tumor colonization. Subcutaneous tumor growth and tumor cell metastasis from primary tumors were also analyzed. Apoptosis of tumor cells was measured in lung tissues following melanoma cell injection. RESULTS: Results show the in vitro invasion of cystatin C over-expressing cells was dramatically inhibited. Lung tumor colonization was also reduced. Increased tumor cell apoptosis was found to be an important factor and may be related to the reduced tumor burden noted in this system of melanoma metastasis. CONCLUSION: Cysteine proteases therefore, may be a target for future anti-metastatic therapies. BioMed Central 2005-05-17 /pmc/articles/PMC1156918/ /pubmed/15904519 http://dx.doi.org/10.1186/1475-2867-5-14 Text en Copyright © 2005 Ervin and Cox; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Primary Research Ervin, Heather Cox, James L Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression |
title | Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression |
title_full | Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression |
title_fullStr | Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression |
title_full_unstemmed | Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression |
title_short | Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression |
title_sort | late stage inhibition of hematogenous melanoma metastasis by cystatin c over-expression |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156918/ https://www.ncbi.nlm.nih.gov/pubmed/15904519 http://dx.doi.org/10.1186/1475-2867-5-14 |
work_keys_str_mv | AT ervinheather latestageinhibitionofhematogenousmelanomametastasisbycystatincoverexpression AT coxjamesl latestageinhibitionofhematogenousmelanomametastasisbycystatincoverexpression |